-
Radiotherapy Planning Software Approved for Marketing
2023-05-23
Recently, the innovative product radiotherapy planning software of Shanghai United Imaging Healthcare Co. Ltd. is approved by China NMPA.
-
Intravascular Imaging Device Approved for Marketing
2023-05-16
Recently, the innovative product Intravascular Imaging Device (Novasight Hybrid System) of Conavi Medical Inc.is approved by China NMPA.
-
Computer Aided Detection Software for Intestinal Polyps in Lower Gastrointestinal Endoscopy Approved for Marketing
2023-05-12
Recently, the innovative product Computer Aided Detection Software for Intestinal Polyps in Lower Gastrointestinal Endoscopy of Wuhan ENDOANGEL Medical Technology Co., Ltd is approved by China NMPA.
-
Self-expanding Radioactive Seed-Carried Biliary Stent Approved for Marketing
2023-05-11
On May 11, 2023, the innovative product Self-expanding Radioactive Seed-Carried Biliary Stent of Rongsheng (Nanjing) Medical Technology Co., Ltd. is approved by NMPA. By far 200 innovative medical devices have been approved by NMPA.
-
Befotertinib Mesylate Capsules Approved for Marketing
2023-05-31
Recently, the Class I innovative product Befotertinib Mesylate Capsules (Chinese trade name: 赛美纳) of Betta Pharmaceuticals Co., Ltd. is approved by China NMPA.
-
Alfosbuvir Tablets Approved for Marketing
2023-05-17
Recently, the Class-1 innovative drug Alfosbuvir Tablets (Chinese trade name:圣诺迪) of Nanjing Sanhome Pharmaceutical Co., Ltd. is approved for marketing through the priority review and approval procedure by China NMPA.
